» Articles » PMID: 26459660

Non Motor Subtypes and Parkinson's Disease

Overview
Specialty Neurology
Date 2015 Oct 14
PMID 26459660
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Non motor symptoms (NMS) represent a significant burden in Parkinson's disease (PD) with numerous studies highlighting the importance of NMS both in "pre-motor" phase of PD as well as throughout the course of disease. In part this has led the international Parkinson and Movement Disorder Society (IPMDS) task force to attempt a re-definition of PD incorporating NMS and not base the diagnosis solely on motor symptoms. While motor subtypes within PD have been recognized and researched, recent clinical and neurobiological research suggests the existence of discrete non motor subtypes in PD, particularly in untreated (drug naïve) and early PD patients. Several independent observers have reported specific "clusters of NMS dominant PD" using a data driven approach in early and untreated PD patients while others have reported on the burden of NMS in untreated PD and specific NMS dominant phenotypes in untreated or treated PD using observational case series based data. In this review we report on specific NMS dominant phenotypes of PD as described in the literature using clinical observational studies and address pathophysiological concepts. A proposal for several NMS subtypes are reported combining clinical reports with, where possible, evidence base supporting probable biomarkers.

Citing Articles

Clinical features in Parkinson's disease: characterization of urinary symptoms according to Parkinson disease subtype.

Gubbiotti M, Ditonno F, Brahimi E, Rosadi S, Rubilotta E Int Urol Nephrol. 2025; .

PMID: 40019611 DOI: 10.1007/s11255-025-04435-z.


Non motor Parkinson: subtypes, biomarkers, stepped care and a journal!.

Chaudhuri K, Poplawska-Domaszewicz K, Subramanian I, Jost W J Neural Transm (Vienna). 2025; .

PMID: 39954077 DOI: 10.1007/s00702-025-02895-2.


Cerebral Amyloid-β Deposition, Axial Features, and Cognitive Alterations in Patients with Parkinson's Disease Treated with Bilateral STN-DBS: A Long-Term Cohort Study.

Cavallieri F, Fraternali A, Arnone A, Campanini I, Marti A, Gessani A J Pers Med. 2024; 14(12).

PMID: 39728063 PMC: 11676129. DOI: 10.3390/jpm14121150.


Non-Categorical Analyses Identify Rotenone-Induced 'Parkinsonian' Rats Benefiting from Nano-Emulsified Punicic Acid (Nano-PSO) in a Phenotypically Diverse Population: Implications for Translational Neurodegenerative Therapies.

Sanchez-Camacho J, Gomez-Chavarin M, Galindo-Solano N, Padilla-Cortes P, Maldonado-Garcia J, Perez-Sanchez G Int J Mol Sci. 2024; 25(23).

PMID: 39684350 PMC: 11640963. DOI: 10.3390/ijms252312635.


Sleep-related respiratory disruptions and laterodorsal tegmental nucleus in a mouse model of Parkinson's disease.

Miranda N, Oliveira L, Moreira T, Ramirez J, Kalume F, Takakura A iScience. 2024; 27(11):111251.

PMID: 39563887 PMC: 11574806. DOI: 10.1016/j.isci.2024.111251.